<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23-viruses-10-00211">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lee</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>D.E.</given-names>
   </name>
   <name>
    <surname>Jang</surname>
    <given-names>K.S.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Cho</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Gemcitabine, a broad-spectrum antiviral drug, suppresses enterovirus infections through innate immunity induced by the inhibition of pyrimidine biosynthesis and nucleotide depletion</article-title>
  <source>Oncotarget</source>
  <year>2017</year>
  <volume>8</volume>
  <fpage>115315</fpage>
  <lpage>115325</lpage>
  <pub-id pub-id-type="doi">10.18632/oncotarget.23258</pub-id>
  <?supplied-pmid 29383162?>
  <pub-id pub-id-type="pmid">29383162</pub-id>
 </element-citation>
</ref>
